What is the interpretation of an ultrasound showing a markedly enlarged uterus measuring 13.3 × 7.7 cm with heterogeneous myometrial echotexture, no discrete fibroid, an endometrial thickness of 1.1 cm, and no free pelvic fluid or adnexal mass?

Ultrasound Interpretation: Enlarged Uterus with Heterogeneous Myometrium

This ultrasound is most consistent with adenomyosis, and the endometrial thickness of 1.1 cm requires tissue sampling if the patient is postmenopausal.

Primary Myometrial Findings: Adenomyosis

The combination of markedly enlarged uterus (13.3 × 7.7 cm) with heterogeneous myometrial echotexture and no discrete fibroid is highly suggestive of diffuse adenomyosis 1.

Key Diagnostic Features Present:

• Heterogeneous myometrial echotexture is the most common sonographic finding in adenomyosis, present in approximately 80% of cases, though it has limited specificity 2, 3.
• Globular uterine enlargement (bulky uterus) is a characteristic feature that, when combined with heterogeneous myometrium, increases diagnostic specificity to 91-93% 4, 2.
• Absence of discrete fibroids helps distinguish diffuse adenomyosis from leiomyomas, though the two conditions frequently coexist 1.

Diagnostic Accuracy Considerations:

Transvaginal ultrasound demonstrates pooled sensitivity of 82.5% and specificity of 84.6% for adenomyosis diagnosis 1. The absence of additional specific features (myometrial cysts, subendometrial linear striations, or ill-defined endometrial-myometrial junction) does not exclude adenomyosis, as these findings are present in only 50-84% of cases 5, 2, 6.

Common pitfall: Heterogeneous myometrium alone has poor specificity and can be seen in normal myometrium or with fibroids 2. However, when combined with globular enlargement and absence of discrete masses, adenomyosis becomes the leading diagnosis 4, 2.

Endometrial Assessment: Critical Next Steps

The endometrial thickness of 1.1 cm (11 mm) requires immediate clinical correlation with menopausal status 1, 7.

If Patient is Postmenopausal:

• Endometrial tissue sampling is mandatory because thickness ≥5 mm in postmenopausal women warrants evaluation for endometrial cancer or hyperplasia 1, 7.
• An 11 mm endometrium far exceeds the 4 mm threshold that provides >99% negative predictive value for cancer 1, 7.
• Ultrasound cannot determine the etiology of endometrial thickening—only histologic sampling can differentiate hyperplasia, polyps, or malignancy 1.

If Patient is Premenopausal:

• No validated upper limit exists for endometrial thickness in premenopausal women, as thickness varies with menstrual cycle phase 1.
• Endometrial pathology can be present even with thickness <5 mm in premenopausal women 1.
• Clinical symptoms (abnormal uterine bleeding, pelvic pain) should guide the decision for tissue sampling rather than thickness alone 1.

Additional Endometrial Considerations:

Abnormal echogenicity or texture of the endometrium correlates with significant pathology independent of measured thickness 1. The report does not describe endometrial echotexture, but any heterogeneity or irregularity would strengthen the indication for sampling 1.

Recommended Next Steps Algorithm

Step 1: Determine Menopausal Status

• Postmenopausal → Proceed directly to endometrial tissue sampling (biopsy, D&C, or hysteroscopy) 1, 7.
• Premenopausal → Correlate with symptoms and menstrual cycle timing 1.

Step 2: Consider Advanced Imaging if Diagnosis Unclear

• MRI pelvis with contrast and diffusion-weighted imaging is the gold standard for confirming adenomyosis when ultrasound findings are equivocal or coexisting pathology is suspected 1, 4.
• MRI has sensitivity ~78% and specificity ~93% for adenomyosis and can better visualize the endometrium even in the presence of myometrial pathology 1, 4.
• Saline infusion sonohysterography can further characterize endometrial abnormalities if focal pathology (polyp vs. submucosal fibroid) is suspected, though it cannot reliably exclude malignancy 1.

Step 3: Exclude Rare but Critical Differential

While adenomyosis is most likely, leiomyosarcoma cannot be definitively excluded by ultrasound alone 8. However, conventional imaging (including MRI) cannot reliably differentiate fibroids from sarcomas 8. Clinical red flags include rapid uterine growth, postmenopausal presentation, or atypical symptoms 8.

Clinical Implications

Adenomyosis is a common cause of abnormal uterine bleeding and pelvic pain in premenopausal women, with symptoms typically peaking in the perimenopausal years 8, 5. Treatment options range from medical management (GnRH agonists, levonorgestrel IUD, NSAIDs) to uterine-sparing procedures (endometrial ablation, uterine artery embolization) to definitive hysterectomy 8, 9.

The absence of free fluid and adnexal masses is reassuring and argues against acute complications such as ovarian torsion, ruptured cyst, or ectopic pregnancy 1.

Key caveat: Adenomyosis detection on ultrasound may be limited when coexisting fibroids are present, with sensitivity dropping from 97.8% to 33.3% in such cases 1. This report describes no discrete fibroids, which actually improves diagnostic confidence for adenomyosis 1.